Comparison of Glargine and Oral Antidiabetic Drugs (OADs) in Newly Diagnosed Type 2 Diabetes
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The investigators designed this prospective, randomized control study to compare the efficacy
and safety between the basal insulin glargine therapy and metformin-based OADs after
correction of the glucose toxicity with a short period of intensive insulin therapy.